Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

European Registry on the Management of Helicobacter Pylori Infection

Next Previous
X
Search
Trial Profile

European Registry on the Management of Helicobacter Pylori Infection

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jan 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tripotassium dicitrato bismuthate/tetracycline/metronidazole (Primary)
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Acronyms Hp-EuReg

    • Most Recent Events

    • 05 Dec 2022 Results (n=2144) reporting eight-year experience in patients from the European Registry using data collected and quality reviewed until Oct 2021 at Asociacion Espanola de Gastroenterologia-Research Electronic Data Capture published in the Gut
    • 11 Oct 2022 Results(n=6,069) assessing the effectiveness and safety of the three in one single capsule in the European Registry on Helicobacter pylori management presented at the 30th United European Gastroenterology Week
    • 01 Jun 2021 Results published in the American Journal of Gastroenterology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top